Tag Archives: CBIO

Top 10 Heal Care Stocks To Invest In Right Now

Owning the best lithium battery stock is the simple way to profit off the whole electric vehicle industry without having to guess which EV car company will win out.

The rise of electric vehicle stocks might have you thinking about names like Tesla Inc. (NASDAQ: TSLA) or Nio Inc. (NYSE: NIO) for profits. While these have delivered significant growth for investors over the last couple years, their best gains might be in the rearview.

Top 10 Heal Care Stocks To Invest In Right Now: Comp En De Mn Cemig ADS(CIG)

Companhia Energetica de Minas Gerais CEMIG, incorporated on May 22, 1952, is a Brazil-based holding company mainly engaged in the generation, transmission and distribution of electricity. The Company operates through the segments: Generation, Transmission, Distribution, Telecom, Gas and Other. As of December 31, 2014, the Company generated electricity at 78 hydroelectric plants, three thermoelectric plants and 23 wind farms, with total installed capacity of 7,716 Megawatts. Of this capacity, the hydroelectric plants had a total of 7,334 Megawatts, the thermal plants 184 Megawatts, and the wind farms 199 Megawatts. The Company’s electric power transmission business consists of transporting power from the facilities where it is generated to points of consumption, distribution networks and Free Consumers. The transmission network consists of power transmission lines and substations with voltage of 230 kilovolts or more.

The Company’s distribution operation consists of transfers of electricity from distribution substations to final consumers. It includes four public service electricity distribution concession contracts in the State of Minas Gerais, granting rights to commercial operation of services related to the supply of electricity to captive consumers in municipalities in its concession area, including consumers that may be eligible, under the legislation, to become Free Consumers. The concession area of Cemig Distribution covers approximately 219,103 square miles, or 96.7% of the territory of the State of Minas Gerais.

As of December 31, 2014, the Company’s electricity system consisted of 316,500 miles of distribution lines, through which it supplied 27,011 Gigawatt hour to 8.0 million captive consumers and transported 17,448 Gigawatt hour to 417 Free Consumers. As of December 31, 2014, the total volume of electricity distributed was 44,459 Gigawatt hour. The Company is also engaged in the following businesses: telecommunications, through its consolidated subsidiary Cemig T! elecomunicacoes S.A.; national and international energy solutions consulting business, through its subsidiary Efficientia S.A.; exploitation of natural gas, through five consortia, including Exploration Consortium SF-T-104, Exploration Consortium SF-T-114, Exploration Consortium SF-T-120, Exploration Consortium SF-T-127, and Exploration Consortium REC-T-163; sale and trading of electricity, through structuring and intermediation of purchase and sale transactions, trading electricity in the Free Market, through its wholly owned subsidiaries Cemig Trading S.A. and Empresa de Servicos de Comercializacao de Energia Eletrica S.A. and Cemig Comercializadora de Energia Incentivada S.A.; acquisition, transport and distribution of gas and its sub products and derivatives through Companhia de Gas de Minas Gerais (Gasmig), and technology systems and systems for operational management of public service concessions, including companies operating in electricity, gas, water and sewerage and other utility companies, through Axxiom Solucoes Tecnologicas S.A.

Advisors’ Opinion:

  • [By Max Byerly]

    CEMIG (NYSE:CIG) and Huaneng Power International (NYSE:HNP) are both mid-cap utilities companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.

  • [By Rich Smith]

    Shares of Brazilian electric utility Companhia Energetica de Minas Gerais (NYSE:CIG) gained 9.4% on the day.

    Companhia de Saneamento Basico do Estado de Sao Paulo (NYSE:SBS), a Brazilian wastewater treatment company, closed 9.6% higher.

  • [By Stephan Byrd]

    CEMIG (NYSE:CIG) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 10,718,816 shares, a growth of 174.6% from the May 31st total of 3,903,277 shares. Based on an average daily volume of 6,056,542 shares, the short-interest ratio is presently 1.8 days.

Top 10 Heal Care Stocks To Invest In Right Now: Activision Blizzard, Inc(ATVI)

Activision Blizzard, Inc. develops and publishes online, personal computer (PC), video game console, handheld, mobile, and tablet games worldwide. The company develops and publishes interactive entertainment software products through retail channels or digital downloads; and downloadable content to a range of gamers. It also publishes online subscription-based games in the massively multiplayer online role-playing game category; and real-time strategy and role-playing games. In addition, the company maintains a proprietary online-game related service, Battle.net that facilitates the creation of user generated content, digital distribution, and online social connectivity in its games. Further, it provides warehousing, logistical, and sales distribution services to third-party publishers of interactive entertainment software; and manufacturers of interactive entertainment hardware products. The company serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, game specialty stores, and consumers through third-party distribution, licensing arrangements, and direct digital purchases. Activision Blizzard, Inc. is headquartered in Santa Monica, California.

Advisors’ Opinion:

  • [By ]

    There are a number of ways you can take advantage of this promising industry. You could invest in the “big boys” like Electronic Arts (Nasdaq: EA), which makes popular franchises FIFA soccer, Madden NFL, Apex Legends, and the Star Wars series Battlefront. Then there’s Activision Blizzard (Nasdaq: ATVI) which produces games like World of Warcraft, Call of Duty, Candy Crush, and Overwatch.

  • [By Motley Fool Staff]

    For this episode, it’s time to check in on not one but two such samplers. First, it’s been one year since he offered up “Five Stocks I Own That You Should Too.” Those were Activision Blizzard(NASDAQ:ATVI), Alphabet(NASDAQ:GOOGL) (NASDAQ:GOOG),Intuitive Surgical(NASDAQ:ISRG), Match Group(NASDAQ:MTCH), and Zillow(NASDAQ:Z) (NASDAQ:ZG), and he’ll review their progress with senior analystJim Mueller.

  • [By Keith Noonan]

    The interactive entertainment industry is a large, fast-growing market that still has lots of potential.Companies that can continue adapting to — and shaping — the demands of that industry are poised to deliver great returns for shareholders. With that in mind,Take-Two Interactive (NASDAQ:TTWO),Tencent Holdings (NASDAQOTH:TCEHY), Activision Blizzard (NASDAQ:ATVI),Electronic Arts (NASDAQ:EA), andCapcom (NASDAQOTH:CCOEF)stand out as top gaming stocks for the long term.

Top 10 Heal Care Stocks To Invest In Right Now: Catalyst Biosciences, Inc. (CBIO)

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. Its product pipeline includes CB 813d, a Factor VIIa drug candidate that completed a Phase I clinical trials evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity in severe hemophilia A and B patients with and without inhibitors. The companys preclinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of patients with hemophilia B; and a Factor Xa variant. It is also developing CB 2782, an anti-C3 inflammation development candidate for the treatment of delayed graft function in kidney transplants; and an ophthalmic anti-C3 candidate for treatment of dry age-related macular degeneration. The company has collaboration agreement with Pfizer, Inc. for the development of human Factor VIIa products; and ISU Abxis for development and manufacturing of the Factor IX products through Phase I/II clinical trials. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Catalyst Biosciences (CBIO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Catalyst Biosciences Inc. (NASDAQ: CBIO) is scheduled to present interim data from its Phase 2 study of Marzeptacog alfa (MarzAA) on July 18. This data will be pertaining to the subcutaneous efficacy trial in individuals with hemophilia A or B with inhibitors to evaluate the ability of MarzAA to minimize spontaneous bleeding episodes.

Top 10 Heal Care Stocks To Invest In Right Now: Chicopee Bancorp, Inc.(CBNK)

Chicopee Bancorp, Inc., incorporated on March 14, 2006, is a bank holding company. The Company provides a range of financial services to individuals and businesses through its bank subsidiary, Chicopee Savings Bank (the Bank). The Bank is a state-chartered savings bank operating over eight branch offices, and a lending and operation center in Western Massachusetts. The Banks’s business consists of making loans to its customers and investing in a range of investment securities. The Bank funds these lending and investment activities with deposits from the general public, funds generated from operations and borrowings. The Bank also provides access to insurance and investment products through its Financial Services Division. Through Linsco/Private Ledger (LPL), the Bank offers customers a range of non-deposit investment products, including mutual funds, debt, equity and government securities, retirement accounts, insurance products and fixed and variable annuities.

Lending Activities

The Company originates one- to four-family real estate loans, commercial real estate loans, residential and commercial construction loans, commercial and industrial loans, home equity lines-of-credit, fixed rate home equity loans and other consumer loans under its lending activity. The Company’s total loan portfolio is approximately $585.7 million. The total residential real estate loan portfolio is over $127.6 million. It offers fixed-rate and adjustable-rate loans with terms of over 30 years. The Company offers fixed-rate residential real estate loans secured by one- to four-family residences with terms between 10 and 30 years. It also offers adjustable-rate mortgage loans. The Company’s commercial real estate loans include commercial construction and residential investment loan balances and interest income. The Bank’s total commercial real estate loans are approximately $287.8 million. The commercial real estate and residential investment loans are secured by apartment buildings and properties us! ed for business purposes, such as office buildings, industrial facilities and retail facilities. The Company’s total construction loans are over $56.6 million. The Company originates over $26.3 million in commercial and industrial loans. The Company has approximately $71.5 million in commercial and industrial loans. It offers automobile and recreational vehicle loans secured by new and used vehicles.

Investment Activities

The Company invests in various types of liquid assets, including marketable equity securities, the United States Treasury obligations, securities of various government sponsored enterprises and municipal governments, deposits at the FHLB and certificates of deposit of federally insured institutions. Its investment portfolio consists of tax-exempt industrial revenue bonds, certificates of deposit, collateralized mortgage obligations and investment-grade marketable equity securities. The Company’s total investment securities are approximately $33.36 million.

Deposit Activities and Other Sources of Funds

The Company’s sources of funds are deposits, principal and interest payments on loans and investments, advances from the Federal Home Loan Bank of Boston (FHLB) and proceeds from loan sales. Its depositors are residents of the Commonwealth of Massachusetts. Deposits are attracted, by advertising and through its Website, from within its market areas through the offering of a selection of deposit instruments, including non-interest-bearing demand accounts (such as checking accounts), interest-bearing accounts (such as negotiable order of withdrawal (NOW) and money market deposit accounts), regular savings accounts (such as passbook accounts) and certificates of deposit. The Company’s total deposits are approximately $507.1 million.

Subsidiary Activities

The Company conducts its business activities through its subsidiaries, the Bank and Chicopee Funding Corporation. The Bank’s subsidiaries include CSB Colts, Inc., ! CSB Inves! tment Corp. and Cabot Realty L.L.C. CSB Colts, Inc. is engaged in buying, selling and holding securities on its own behalf and consists of tax-exempt industrial revenue bonds. CSB Investment Corp. is engaged in buying, selling and holding securities on its own behalf and consists of collateralized mortgage obligations and marketable equity securities. Cabot Realty L.L.C. is a liability company, which holds other real estate owned (OREO).

The Bank competes with Bank of America Corporation, Santander Bank, N.A., Citizens Financial Group, First Niagara Financial Group, Inc. and TD Bank, Inc.

Advisors’ Opinion:

  • [By Shane Hupp]

    Capital Bancorp (NASDAQ: CBNK) is one of 141 public companies in the “National commercial banks” industry, but how does it contrast to its rivals? We will compare Capital Bancorp to related businesses based on the strength of its analyst recommendations, profitability, valuation, earnings, dividends, risk and institutional ownership.

  • [By Paul Ausick]

    Capital Bancorp Inc. (NASDAQ: CBNK) raised $28 million selling 2.2 million shares priced at $12.50, the low end of the expected range. Shares got a 2% pop on the Friday IPO.

Top 10 Heal Care Stocks To Invest In Right Now: ConnectOne Bancorp, Inc.(CNOB)

ConnectOne Bancorp, Inc. operates as the bank holding company for ConnectOne Bank that provides various banking products and services. The company offers a range of deposit products, including personal and business checking accounts, retirement accounts, money market accounts, time and savings accounts, and NOW accounts. It also provides personal and commercial business loans on a secured and unsecured basis; revolving lines of credit; commercial mortgage loans; residential mortgages on primary and secondary residences; home equity loans; bridge loans; and other personal purpose loans. In addition, the company offers brokerage services, insurance and annuities, mutual funds, and financial planning services. Further, it provides credit cards, wire transfers, and safe deposit boxes; access to automated teller services; and Internet banking, treasury direct, ACH origination, lockbox, mobile banking, and remote deposit capture banking services. As of January 27, 2016, the company operated 21 banking offices. It serves small-to-medium sized businesses, high net worth individuals, professional practices, and consumer and retail customers. The company was formerly known as Center Bancorp, Inc. and changed its name to ConnectOne Bancorp, Inc. in July 2014. ConnectOne Bancorp, Inc. was founded in 1982 and is headquartered in Englewood Cliffs, New Jersey.

Advisors’ Opinion:

  • [By Joseph Griffin]

    ValuEngine cut shares of ConnectOne Bancorp (NASDAQ:CNOB) from a sell rating to a strong sell rating in a report published on Tuesday morning.

    CNOB has been the subject of several other reports. Zacks Investment Research lowered shares of ConnectOne Bancorp from a hold rating to a sell rating in a report on Wednesday, February 13th. TheStreet upgraded shares of ConnectOne Bancorp from a c+ rating to a b- rating in a research report on Monday, February 25th. Finally, BidaskClub upgraded shares of ConnectOne Bancorp from a strong sell rating to a sell rating in a research report on Wednesday, January 2nd. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a strong buy rating to the stock. ConnectOne Bancorp has an average rating of Hold and an average target price of $35.00.

  • [By Max Byerly]

    ConnectOne Bancorp Inc (NASDAQ:CNOB) has been assigned an average rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $33.50.

  • [By Ethan Ryder]

    Media headlines about Center Bancorp (NASDAQ:CNOB) have trended somewhat positive on Tuesday, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Center Bancorp earned a news impact score of 0.09 on Accern’s scale. Accern also assigned press coverage about the financial services provider an impact score of 47.8586921520597 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top 10 Heal Care Stocks To Invest In Right Now: Penumbra, Inc.(PEN)

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PXSLIM, and Velocity brands; aspiration based thrombectomy systems and accessory devices under the Penumbra System brand; and stent retriever for mechanical thrombectomy under the 3D brand. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands; and neurovascular stents for stent-assisted coiling in large and wide-neck aneurysms under the LIBERTY Stent brand. In addition, the company offers neurosurgical tools for the removal of tissue and fluids under the Apollo System brand; and detachable embolic coil systems for peripheral embolization under the RUBY Coil brand, as well as Lantern, a microcatheter for the delivery of detachable coils and occlusion devices. Further, it provides detachable, microcatheter-deliverable occlusion devices under the POD (penumbra occlusion device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand, as well as POD Packing Coil, a device for use with RUBY Coil and POD for vessel occlusion. The company sells its products through direct sales organizations and distributors to hospitals in neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Penumbra Inc (NYSE:PEN)Q42018 Earnings Conference CallFeb. 05, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Mission Wealth Management LP decreased its stake in shares of Penumbra Inc (NYSE:PEN) by 8.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,723 shares of the company’s stock after selling 1,040 shares during the period. Mission Wealth Management LP’s holdings in Penumbra were worth $1,433,000 as of its most recent SEC filing.

Top 10 Heal Care Stocks To Invest In Right Now: Sarepta Therapeutics, Inc.(SRPT)

We are a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. Applying our proprietary, highly-differentiated and innovative platform technologies, we are able to target a broad range of diseases and disorders through distinct RNA-targeted mechanisms of action. We are primarily focused on rapidly advancing the development of our potentially disease-modifying DMD drug candidates, including our lead DMD product candidate, eteplirsen, designed to skip exon 51. On August 25, 2015, we announced the FDA filing of our NDA for eteplirsen for the treatment of DMD amenable to exon 51 skipping. The FDA postponed the Advisory Committee meeting for the review of the eteplirsen NDA previously scheduled for January 22, 2016 due to severe weather.   Advisors’ Opinion:

  • [By ]

    Some of my readers may know Sarepta (Nasdaq: SRPT) well. This $9 billion gene-therapy company already has an FDA-approved product. Exondys 51, the first-ever FDA-approved treatment for a rare but deadly genetic disease called Duchenne muscular dystrophy (DMD), is already on the market. And just last month, the FDA granted priority review for SRPT’s second treatment for DMD, golodirsen, for DMD patients with a different genetic mutation.

  • [By Dan Caplinger]

    Wednesday was a bad day on Wall Street, as most major indexes finished lower. Small-cap stocks were hit harder than their large-cap counterparts, due in part to readings on the U.S. economy that signaled the possibility of a slowdown in the future. Moreover, downward pressure from some high-profile players weighed on overall market sentiment. NIO (NYSE:NIO), Brown-Forman (NYSE:BF-A) (NYSE:BF-B), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers. Here’s why they did so poorly.

Top 10 Heal Care Stocks To Invest In Right Now: John Hancock Tax-Advantaged Global Shareholder Yield Fund(HTY)

John Hancock Tax-Advantaged Global Shareholder Yield Fund (the Fund) is a diversified, closed-end management investment company. The Funds investment objective is to provide a high level of total return consisting of a high level of current income and gains and long term capital appreciation. The Fund will seek to achieve favorable after-tax returns for its shareholders by seeking to minimize the federal income tax consequences on income and gains generated by the Fund. Under normal market condition, the Fund will invest at least 80% of its total assets in a diversified portfolio of dividend-paying stocks of issuers located around the world. The Fund also intends to write call options on a variety of both U.S. and non-U.S. broad-based indices. It invests in sectors, such as utilities, telecommunication services, consumer staples, financials, industrials, energy, healthcare, information technology, consumer discretionary and materials. The Funds investment advisor is John Hancock Advisers, LLC, a wholly owned indirect subsidiary of Manulife Financial Corporation. Its sub-advisors are Epoch Investment Partners, Inc. and Analytic Investors, LLC.

Advisors’ Opinion:

  • [By Shane Hupp]

    John Hancock Tax-Advntgd Glbl SH Yld Fd (NYSE:HTY) declared a quarterly dividend on Thursday, August 23rd, Wall Street Journal reports. Shareholders of record on Friday, September 14th will be paid a dividend of 0.16 per share on Friday, September 28th. This represents a $0.64 annualized dividend and a yield of 7.68%. The ex-dividend date is Thursday, September 13th.

Top 10 Heal Care Stocks To Invest In Right Now: Telefonica SA(TEF)

Telefonica, S.A. provides fixed and mobile telephony services primarily in Spain, rest of Europe, and Latin America. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone; local, domestic, and international long distance and fixed-to-mobile communications; corporate communications; video telephony; supplementary and business-oriented value-added services; network services; leasing and sale of handset equipment; and telephony information services. The company?s Internet and broadband multimedia services comprise Internet service provider service; portal and network services; retail and wholesale broadband access; narrowband switched access to Internet; naked ADSL, a broadband connection; residential-oriented value-added services; companies-oriented value-added services; television services, such as IPTV, cable television, and satellite television; and Fiber to the Home, a service for high speed Internet access and digital video recording. Its data and business-solutions services principally include leased lines; virtual private network services; fiber optics services; the provision of hosting and application; outsourcing and consultancy services; desktop services; and system integration and professional services. The company?s wholesale services for telecommunication operators primarily comprise domestic interconnection services; international wholesale services; leased lines for other operators? network deployment; local loop leasing under the unbundled local loop regulation framework; and bit stream services. It also offers various mobile and related services and products that include mobile voice services, value added services, mobile data and Internet services, wholesale services, corporate services, roaming, fixed wireless, and trunking and paging services. The company has a strategic alliance with China Unicom (Hong Kong) Limited. Telefonica, S.A. was founded in 1924 and is headquartered in Madrid, Spai n.

Advisors’ Opinion:

  • [By Logan Wallace]

    Telefonica (NYSE:TEF) and TELE2 AB/ADR (OTCMKTS:TLTZY) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

  • [By Joseph Griffin]

    Telefonica S.A. (NYSE:TEF) has been given an average rating of “Hold” by the fifteen analysts that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating on the company.

Top 10 Heal Care Stocks To Invest In Right Now: Independence Realty Trust, Inc.(IRT)

Independence Realty Trust, Inc., incorporated on March 26, 2009, is an externally managed and advised apartment real estate investment trust (REIT). The Company’s business consists of owning, managing, operating, leasing, acquiring, developing, investing in, and disposing of real estate assets. It owns and operates a portfolio of garden style and mid-rise apartment communities in the Southeastern United States. The Company’s portfolio consists of approximately 50 apartment properties containing an aggregate of over 13,700 apartment units. The Company’s portfolio has an average occupancy of approximately 93.6%. The Company conducts its business through a traditional umbrella partnership REIT (UPREIT) structure in which its properties are owned by its operating partnership, Independence Realty Operating Partnership, LP (IROP), directly or through subsidiaries. The Company is the sole general partner of IROP.

The Company’s apartment properties include Belle Creek, Copper Mill, Crestmont, Cumberland Glen, Heritage Trace, Tresa at Arrowhead, Centrepoint, Runaway Bay, Berkshire Square, The Crossings, Reserve at Eagle Ridge, Windrush, Heritage Park, Raindance, Augusta, Invitational, King’s Landing, Carrington Park, Arbors at the Reservoir, Walnut Hill, Lenoxplace, Stonebridge Crossing, Bennington Pond, Prospect Park, Brookside, Jamestown, Meadows, Oxmoor, Stonebridge at the Ranch, Iron Rock Ranch, Bayview Club, Arbors River Oaks, Aston, Avenues at Craig Ranch, Bridge Pointe, Creekstone at RTP, Fountains Southend, Fox Trails, Lakeshore on the Hill, Millenia 700, Miller Creek at German Town, Pointe at Canyon Ridge, St James at Goose Creek, Talison Row at Daniel Island, The Aventine Greenville, Trails at Signal Mountain, Vue at Knoll Trail, Waterstone at Brier Creek, Waterstone Big Creek and Westmont Commons. The Company is managed by a subsidiary of RAIT Financial Trust (RAIT), a real estate company organized as an internally managed REIT.

Advisors’ Opinion:

  • [By Joseph Griffin]

    BlackRock Inc. grew its position in Independence Realty Trust Inc (NYSE:IRT) by 17.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 14,596,051 shares of the real estate investment trust’s stock after purchasing an additional 2,128,304 shares during the period. BlackRock Inc. owned about 0.17% of Independence Realty Trust worth $150,484,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Independence Realty Trust Inc (NYSE:IRT) has been given a consensus rating of “Buy” by the nine ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $10.75.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Independence Realty Trust (IRT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own Right Now

Primo Water (NASDAQ:PRMW) had its price objective hoisted by analysts at BMO Capital Markets from $15.00 to $16.00 in a research note issued on Thursday. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 0.88% from the company’s current price.

PRMW has been the subject of a number of other research reports. ValuEngine upgraded shares of Primo Water from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. BidaskClub lowered shares of Primo Water from a “hold” rating to a “sell” rating in a research note on Tuesday, March 13th. Barrington Research restated a “buy” rating and set a $20.00 price target on shares of Primo Water in a research note on Friday, April 6th. B. Riley set a $18.00 price target on shares of Primo Water and gave the company a “buy” rating in a research note on Monday, March 5th. Finally, William Blair began coverage on shares of Primo Water in a research note on Thursday. They set an “outperform” rating for the company. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $17.50.

Top 10 Medical Stocks To Own Right Now: THL Credit Senior Loan Fund(TSLF)

THL Credit Senior Loan Fund is a non-diversified, closed-end management investment company (Fund). The Fund’s investment objective is to provide current income and preservation of capital primarily through investments in United States dollar-denominated senior secured corporate loans and notes. Under normal market conditions, the Fund will invest 100% of its Managed Assets in the securities of issuers located in North America and does not currently intend to invest a material amount of its Managed Assets outside the United States. It invests in sectors, such as Business, Services, Healthcare and Pharmaceuticals, Retail, Software, Advertising, Printing and Publishing, and Diversified and Services, among others. Four Wood Capital Advisors LLC serves as the Fund’s investment adviser. Advisors’ Opinion:

Top 10 Medical Stocks To Own Right Now: Catalyst Biosciences, Inc. (CBIO)

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. Its product pipeline includes CB 813d, a Factor VIIa drug candidate that completed a Phase I clinical trials evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity in severe hemophilia A and B patients with and without inhibitors. The company’s preclinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of patients with hemophilia B; and a Factor Xa variant. It is also developing CB 2782, an anti-C3 inflammation development candidate for the treatment of delayed graft function in kidney transplants; and an ophthalmic anti-C3 candidate for treatment of dry age-related macular degeneration. The company has collaboration agreement with Pfizer, Inc. for the development of human Factor VIIa products; and ISU Abxis for development and manufacturing of the Factor IX products through Phase I/II clinical trials. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Catalyst Biosciences (CBIO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Catalyst Biosciences Inc. (NASDAQ: CBIO) is scheduled to present interim data from its Phase 2 study of Marzeptacog alfa (MarzAA) on July 18. This data will be pertaining to the subcutaneous efficacy trial in individuals with hemophilia A or B with inhibitors to evaluate the ability of MarzAA to minimize spontaneous bleeding episodes.

  • [By Joseph Griffin]

    B. Riley lowered shares of Catalyst Biosciences (NASDAQ:CBIO) from a buy rating to a neutral rating in a research report released on Thursday, MarketBeat reports. They currently have $12.50 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $44.00.

  • [By Cory Renauer]

    If you’re looking for biotech stock bargains, the scrap heap isn’t a bad place to start. Hardly a day goes by without a biotech meltdown somewhere, and clinical trial mishaps led to market clubbings for Anika Therapeutics (NASDAQ:ANIK) and Catalyst Biosciences (NASDAQ:CBIO) earlier this week.

Top 10 Medical Stocks To Own Right Now: RELX PLC(RELX)

RELX Group is a global provider of information and analytics for professional and business customers across industries.
Our goal is to help customers make better decisions, get better results and be more productive. We do this by leveraging a deep understanding of our customers to create innovative solutions which combine content and data with analytics and technology in global platforms.
The Group has customers in more than 180 countries and has offices in about 40 countries. The Group employs approximately 30,000 staff.
We operate in four major market segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions.

? Scientific, Technical & Medical helps customers advance science and improve healthcare by providing information and analytical solutions that enable them to make critical decisions, enhance productivity, and improve outcomes.   Advisors’ Opinion:

  • [By Joseph Griffin]

    First Republic Investment Management Inc. acquired a new position in shares of Relx PLC (NYSE:RELX) in the 2nd quarter, Holdings Channel reports. The fund acquired 13,205 shares of the technology company’s stock, valued at approximately $287,000.

  • [By Joseph Griffin]

    Relx PLC (NYSE:RELX)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $20.27 and last traded at $20.29, with a volume of 6975 shares traded. The stock had previously closed at $20.35.

  • [By Joseph Griffin]

    Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Top 10 Medical Stocks To Own Right Now: Cherry Hill Mortgage Investment Corporation(CHMI)

Cherry Hill Mortgage Investment Corporation, incorporated on October 31, 2012, is a residential real estate finance company. The Company is focused on acquiring, investing in and managing residential mortgage assets in the United States. Its principal objective is to generate attractive current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The Company focuses on attaining this objective, subject to market conditions and availability and terms of financing, by selectively constructing and managing a targeted portfolio of Servicing Related Assets, residential mortgage-backed securities (RMBS), prime mortgage loans and other cashflowing residential mortgage assets. The Company operates its business through segments, including investments in RMBS; investments in Servicing Related Assets, and All Other. The Company’s targeted asset classes include servicing related assets consisting of mortgage servicing rights (MSRs) and Excess MSRs; RMBS, including Agency RMBS, residential mortgage pass-through certificates, collateralized mortgage obligations (CMOs) (interest-only security (IO) and inverse IOs) and to-be-announced (TBA), and prime mortgage loans. The Company is externally managed by Cherry Hill Mortgage Management, LLC.

The Company also may generate MSRs through the purchase of prime mortgage loans. Its RMBS strategy focuses primarily on the acquisition and ownership of Agency RMBS that are whole-pool, residential mortgage pass-through certificates. However, from time to time, the Company invests in CMOs, including IOs and inverse IOs. Its RMBS strategy includes selective investments in non-Agency RMBS, including government-sponsored enterprise (GSE) risk-sharing securities.

Advisors’ Opinion:

  • [By Max Byerly]

    Cherry Hill Mortgage Investment (NYSE:CHMI) and Great Portland Estates (OTCMKTS:GPEAF) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

  • [By Ethan Ryder]

    Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Cherry Hill Mortgage Investment Corp (NYSE:CHMI) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 152,335 shares of the real estate investment trust’s stock, valued at approximately $2,721,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.98% of Cherry Hill Mortgage Investment as of its most recent filing with the SEC.

Top 10 Medical Stocks To Own Right Now: Briggs & Stratton Corporation(BGG)

Briggs & Stratton Corporation designs, manufactures, markets, sells, and services air cooled gasoline engines for outdoor power equipment. It operates in two segments, Engines and Products. The Engines segment offers four-cycle aluminum alloy gasoline engines that are used primarily by the lawn and garden equipment industry. Its products are used in various lawn and garden equipment applications, including walk-behind lawn mowers, riding lawn mowers, garden tillers, and snow throwers, as well as products for industrial, construction, agricultural, and other consumer applications that include portable and standby generators, pumps, and pressure washers. This segment also manufactures and sells replacement engines and service parts to sales and service distributors. The Products segment offers portable and standby generators, pressure washers, snow throwers, lawn and garden powered equipment, turf care, and job site products. This segment sells its products through various channels of retail distribution, including consumer home centers, warehouse clubs, mass merchants, and independent dealers under its brands, including Briggs & Stratton, Simplicity, Snapper, Snapper Pro, Ferris, PowerBoss, Allmand, Billy Goat, Murray, Branco, and Victa, as well as other brands, such as Craftsman, GE, and Troy-Bilt. The company serves original equipment manufacturers worldwide. Briggs & Stratton Corporation was founded in 1908 and is headquartered in Wauwatosa, Wisconsin.

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Briggs & Stratton (BGG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jon C. Ogg]

    Generac Holdings Inc. (NYSE: GNRC) was up less than 1% at $59.20 late on Tuesday, but that is actually up by over 6% from last Friday’s close for the generator maker before the storm threat was so imminent. Briggs & Stratton Corp. (NYSE: BGG) is also in that field and its gain of just 0.3% to $20.45 late on Tuesday was actually up only about 1% from last Friday as the company is more diversified

  • [By Motley Fool Transcriber]

    Briggs & Stratton Corporation (NYSE: BGG)Q4 2018 Briggs & Stratton Corp Earnings CallAug. 16, 2018, 2 p.m. EDT

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Medical Stocks To Own Right Now: EP Energy Corporation(EPE)

EP Energy Corporation (EP Energy), incorporated on August 8, 2013, is an independent exploration and production company. The Company is engaged in the acquisition and development of unconventional onshore oil and natural gas properties in the United States. The Company operates through a diverse base of producing assets and are focused on creating value through the development of its drilling inventory located in four areas: the Eagle Ford Shale (South Texas), the Wolfcamp Shale (Permian Basin in West Texas), the Altamont Field in the Uinta Basin (Northeastern Utah) and the Haynesville Shale (North Louisiana). In its operating areas, it has identified approximately 5,710 drilling locations (including over 860 drilling locations to which it has attributed proved undeveloped reserves).

The Company has proved reserves of approximately 546.0 million barrels of oil equivalent (MMBoe) and it has an average net daily production of over 109,680 barrel of oil equivalent per day (Boe/d). Approximately 240 MMBoe of its total proved reserves are proved developed producing assets, which generates an average production of over 109.7 million barrels of oil equivalent per day (MBoe/d) from approximately 1,600 wells. The Company has approximately 300 MMBbls of proved oil reserves, over 90 MMBbls of proved natural gas liquids (NGLs) reserves and approximately 940 billion cubic feet (Bcf) of proved natural gas reserves.

Eagle Ford Shale

The Eagle Ford Shale, located in South Texas, is an unconventional oil plays in the United States. The Eagle Ford formation in La Salle county has approximately 120 feet of net thickness (over 160 feet gross). The Company has approximately 94,150 net (over 88,890 gross) acres in the Eagle Ford, in which it has identified over 970 drilling locations. The Company has approximately 570 net producing wells (over 560 net operated wells) and running one rig in this program. EP Energy’s average net daily production is approximately 58,190 Boe/d.

!

Wolfcamp Shale

The Wolfcamp Shale is located in the Permian Basin. The Wolfcamp A, B and C zones combine for over 750 feet of net (approximately 1,000 feet of gross) thickness. The Company has approximately 178,110 net (over 178,280 gross) acres in the Wolfcamp, in which it has identified approximately 3,260 drilling locations in the Wolfcamp A, B and C zones. EP Energy has approximately 240 net operated producing wells. Its average net daily production is over 19,850 Boe/d.

Altamont

The Altamont field is located in the Uinta Basin in northeastern Utah. The Company’s operations are focused on developing the Altamont Field Complex (consisting of the Altamont, Bluebell and Cedar Rim fields). It owns approximately 180,940 net (over 323,210 gross) acres in Duchesne and Uinta Counties. The Altamont Field Complex has a gross pay interval thickness of over 4,300 feet. Its commingled production is from over 1,500 feet of net stimulated rock. The Company’s activity is focused on the development of its vertical inventory on approximately 80-acre and 160-acre spacing. The Company has identified approximately 1,280 drilling locations. EP Energy has approximately 390 net producing wells (over 380 net operated wells). The Company’s average net daily production is approximately 17,140 Boe/d.

Haynesville Shale

The Company holds natural gas assets in the Haynesville Shale, located in East Texas and Northern Louisiana. The Company’s operations are concentrated primarily in Desoto Parish, Louisiana in the Holly Field. It has approximately 34,170 net (over 52,930 gross) acres in this area. EP Energy has identified over 190 drilling locations. The Company’s average net daily production is approximately 90 million cubic feet per day (MMcf/d).

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    EP Energy Corp  (NYSE:EPE)Q4 2018 Earnings Conference CallMarch 15, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Enterprise GP (EPE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Enterprise GP Holdings L.P. (NYSE:EPE) shares were up 5.5% during trading on Wednesday . The stock traded as high as $2.55 and last traded at $2.51. Approximately 939,243 shares traded hands during mid-day trading, a decline of 13% from the average daily volume of 1,077,065 shares. The stock had previously closed at $2.38.

Top 10 Medical Stocks To Own Right Now: MuniVest Fund, Inc.(MVF)

BlackRock MuniVest Fund, Inc. (the Fund), formerly known as MuniVest Fund, Inc., is a non-diversified, closed-end management investment company. The Fund seeks to provide a high a level of current income exempt from federal income taxes by investing primarily in a portfolio of long-term, investment-grade municipal obligations, the interest on which is exempt from federal income taxes.

BlackRock MuniVest Fund, Inc. may invest in certain securities, whose income return is inversely related to changes in a floating interest rate (inverse floaters). The Fund may invest in swap agreements. The Fund may also purchase and write call and put options. BlackRock MuniVest Fund, Inc.’s investment advisor is BlackRock Advisors, LLC, a wholly owned subsidiary of BlackRock, Inc. The Fund’s sub-advisor is BlackRock Investment Management, LLC.

Advisors’ Opinion:

  • [By Max Byerly]

    BlackRock MuniVest Fund Inc. (NYSEAMERICAN:MVF) declared a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Stockholders of record on Friday, September 14th will be paid a dividend of 0.041 per share by the investment management company on Monday, October 1st. This represents a $0.49 annualized dividend and a dividend yield of 5.57%. The ex-dividend date of this dividend is Thursday, September 13th.

Top 10 Medical Stocks To Own Right Now: Basilea Pharmaceutica Ltd. (BPMUF)

Basilea Pharmaceutica AG is a Switzerland-based company engaged in the research, development and commercialization of pharmaceutical products. The Company focuses on pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology. The Company has a range of drugs to treat drug-resistant bacterial infections, systemic fungal infections and drug-resistant tumors. The Company’s anti-infectives, including isavuconazole and ceftobiprole are in late-stage clinical development, while the novel antibiotic, BAL30072 and the oncology compound, BAL101553 are in clinical phase I. The Company’s subsidiaries include Basilea Pharmaceutica China Ltd., Basilea Pharmaceuticals A/S, Basilea Pharma SAS, Basilea Pharmaceutica Deutschland GmbH, Basilea Pharmaceutica International Ltd., BPh Investitionen Ltd., Basilea Medical Ltd. and Basilea Pharmaceuticals Ltd. Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Basilea Pharmaceutica (BPMUF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called “tumor checkpoint controller” inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.

Top 10 Medical Stocks To Own Right Now: SunCoke Energy Partners, L.P.(SXCP)

SunCoke Energy Partners, L.P., (the “Partnership,” “we,” “our” and “us”), is a Delaware limited partnership formed in July 2012, which primarily produces coke used in the blast furnace production of steel. We also provide coal handling and/or mixing services at our Coal Logistics terminals. At December 31, 2015, we owned a 98.0 percent interest in Haverhill Coke Company LLC (“Haverhill”), Middletown Coke Company, LLC (“Middletown”) and Gateway Energy and Coke Company, LLC (“Granite City”). At December 31, 2015, SunCoke Energy, Inc. (“SunCoke”) owned the remaining 2.0 percent interest in each of Haverhill, Middletown, and Granite City, and, through its subsidiary, owned a 53.9 percent partnership interest in us and all of our incentive distribution rights and indirectly owns and controls our general partner, which holds a 2.0 percent general partner interest in us. Coke is a principal raw material in the blast furnace steelmaking process.   Advisors’ Opinion:

  • [By Stephan Byrd]

    Bramshill Investments LLC cut its stake in SunCoke Energy Partners LP (NYSE:SXCP) by 4.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 113,454 shares of the energy company’s stock after selling 4,786 shares during the period. Bramshill Investments LLC’s holdings in SunCoke Energy Partners were worth $1,702,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE:SXCP) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    Teligent (NASDAQ:TLGT) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Stephan Byrd]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get SunCoke Energy Partners alerts:

    SunCoke Energy Partners LP Declares Quarterly Dividend of $0.40 (SXCP) (americanbankingnews.com) SunCoke Energy Partners (SXCP) Scheduled to Post Earnings on Wednesday (americanbankingnews.com) SunCoke Energy Partners LP (SXCP) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com) Head to Head Survey: SunCoke Energy Partners (SXCP) vs. APERAM/SH N Y REGISTRY SH (APEMY) (americanbankingnews.com)

    Shares of SunCoke Energy Partners traded down $0.05, hitting $15.85, during trading on Friday, MarketBeat reports. 105,181 shares of the company were exchanged, compared to its average volume of 66,406. The firm has a market capitalization of $735.01 million, a price-to-earnings ratio of 9.61 and a beta of 1.44. SunCoke Energy Partners has a fifty-two week low of $14.70 and a fifty-two week high of $21.95. The company has a quick ratio of 0.83, a current ratio of 1.54 and a debt-to-equity ratio of 1.34.

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE: SXCP) and AK Steel (NYSE:AKS) are both small-cap oils/energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Top 10 Medical Stocks To Own Right Now: TG Therapeutics, Inc.(TGTX)

TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. It develops TG-1101 (ublituximab), a novel glycol engineered monoclonal antibody that targets a epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. The company also develops TGR-1202, an orally available phosphoinositide-3-kinase delta inhibitor with nanomolar potency to the delta isoform and high selectivity over the alpha, beta, and gamma isoforms, as well as for hematologic malignancies. In addition, it develops a pre-clinical program to develop the inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4); and anti-PD-L1 and anti-GITR antibody research programs that are in pre-clinical development stage in the field of hematological malignancies. The company has license agreements with LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, and Ildong Pharmaceutical Co. Ltd. for the development and commercialization of TG-1101; Rhizen Pharmaceuticals, SA for the development and commercialization of TGR-1202; and Ligand Pharmaceuticals Incorporated for the development and commercialization of IRAK4 inhibitor technology. It also has a collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Todd Campbell]

    Fueled by trial data, TG Therapeutics (NASDAQ:TGTX) shares skyrocketed 69.5% in February, according to S&P Global Market Intelligence.

    So what

    On Jan. 30, data from phase 1 trials evaluating TG Therapeutics’ ublituximab and umbralisib alongside J&J and AbbVie’s Imbruvica was published in Lancet, a respected industry journal. 

  • [By Logan Wallace]

    Shares of TG Therapeutics Inc (NASDAQ:TGTX) have received a consensus rating of “Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $12.30.

  • [By George Budwell]

    Shares of the B-cell malignancy and autoimmune disease specialist TG Therapeutics (NASDAQ:TGTX) fell by an eye-popping 55.9% last month, according to data from S&P Global Market Intelligence. What triggered this dramatic sell-off?

Hot Undervalued Stocks To Buy Right Now

The oil and gas industry has been a strange market lately. Even though the price of oil is up close to 40% over the past year, the Energy Select Sector SPDR ETF (NYSEMKT:XLE), which is comprised largely of oil and gas companies, is up just 17%. While a 17% return is impressive in its own right, it is still well below the gains of crude oil. While it’s not a surefire sign that the industry is undervalued, it does suggest that those willing to sift through the industry could find some deals as oil hovers around $70 a barrel.

So we asked three of our Motley Fool contributors to each highlight a stock they see as a buy in the oil and gas industry right now. Here’s why they picked ExxonMobil (NYSE:XOM), EOG Resources (NYSE:EOG), and Phillps 66 Partners (NYSE:PSXP). 

XLE price change. Data source: YCharts.

Don’t overlook the long-term potential

Tyler Crowe (ExxonMobil): ExxonMobil has historically been one of the best in the oil business thanks to incredibly disciplined capital allocation. For decades, the market has assigned the company a premium to its peers because it has consistently produced higher rates of return. Recently, though, the company made a few decisions that have made investors question Exxon’s reputation. Its 2010 acquisition of XTO Energy was probably an overpay for mostly shale gas assets and its involvement in extremely expensive projects like Kashagan in Kazakhstan and Gorgon LNG in Australia have lowered return rates. 

Hot Undervalued Stocks To Buy Right Now: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Catalyst Biosciences Inc (NASDAQ:CBIO) rose 2.7% on Wednesday . The stock traded as high as $10.75 and last traded at $10.54. Approximately 41,790 shares traded hands during trading, a decline of 93% from the average daily volume of 568,965 shares. The stock had previously closed at $10.83.

  • [By Joseph Griffin]

    B. Riley lowered shares of Catalyst Biosciences (NASDAQ:CBIO) from a buy rating to a neutral rating in a research report released on Thursday, MarketBeat reports. They currently have $12.50 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $44.00.

  • [By Logan Wallace]

    B. Riley set a $44.00 price target on Catalyst Biosciences (NASDAQ:CBIO) in a report published on Monday. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. B. Riley also issued estimates for Catalyst Biosciences’ Q1 2019 earnings at ($0.85) EPS, Q2 2019 earnings at ($0.91) EPS, Q3 2019 earnings at ($0.98) EPS and Q4 2019 earnings at ($1.13) EPS.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Catalyst Biosciences (CBIO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Dan Caplinger]

    Wall Street continued its downward streak on Monday, with the Dow Jones Industrial Average falling more than 100 points. Most major benchmarks fell more modestly, with a few actually poking into positive territory on the day. Trade-sensitive stocks were among the weakest as investors focused on uncertainty related to tariff disputes between the U.S. and China. But for some other companies, bad news of a different sort was responsible for the drops in their shares. Biogen (NASDAQ:BIIB), Baytex Energy (NYSE:BTE), and Catalyst Biosciences (NASDAQ:CBIO) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Cory Renauer]

    If you’re looking for biotech stock bargains, the scrap heap isn’t a bad place to start. Hardly a day goes by without a biotech meltdown somewhere, and clinical trial mishaps led to market clubbings for Anika Therapeutics (NASDAQ:ANIK) and Catalyst Biosciences (NASDAQ:CBIO) earlier this week.

Hot Undervalued Stocks To Buy Right Now: E*TRADE Financial Corporation(ETFC)

Advisors’ Opinion:

  • [By Max Byerly]

    E*TRADE Financial (NASDAQ:ETFC) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

    First Mid-Illinois Bancshares, Inc. Common Stock (NASDAQ:FMBH) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

  • [By Stephan Byrd]

    E-Trade (NASDAQ:ETFC) last announced its quarterly earnings data on Thursday, April 19th. The financial services provider reported $0.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.79 by $0.09. E-Trade had a net margin of 28.40% and a return on equity of 11.64%. The firm had revenue of $708.00 million during the quarter, compared to analyst estimates of $686.31 million. During the same quarter in the prior year, the firm posted $0.48 earnings per share. E-Trade’s quarterly revenue was up 28.0% on a year-over-year basis. equities research analysts predict that E-Trade will post 3.62 earnings per share for the current fiscal year.

  • [By Jon C. Ogg]

    E*Trade Financial Corp. (NASDAQ: ETFC), which manages assets and charges clients via the classic per-trade commission structure, was up about 1.8% in the past week, as well as up the most of the group (up by 23%) so far in 2018.

Hot Undervalued Stocks To Buy Right Now: First Trust Energy Income and Growth Fund(FEN)

Advisors’ Opinion:

  • [By Max Byerly]

    First Trust Energy Income & Growth Fund (NYSEAMERICAN:FEN) was the target of a significant growth in short interest during the month of September. As of September 28th, there was short interest totalling 48,349 shares, a growth of 530.7% from the September 14th total of 7,666 shares. Based on an average daily volume of 77,969 shares, the days-to-cover ratio is presently 0.6 days.

  • [By Shane Hupp]

    Shares of Frenkel Topping Group Plc (LON:FEN) hit a new 52-week low during mid-day trading on Wednesday after FinnCap lowered their price target on the stock from GBX 65 to GBX 45. FinnCap currently has a corporate rating on the stock. Frenkel Topping Group traded as low as GBX 35 ($0.47) and last traded at GBX 37 ($0.49), with a volume of 388157 shares trading hands. The stock had previously closed at GBX 46.80 ($0.62).

Hot Undervalued Stocks To Buy Right Now: SPX FLOW, Inc.(FLOW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Dynamic Technology Lab Private Ltd increased its position in shares of SPX Flow Inc (NYSE:FLOW) by 38.6% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,824 shares of the industrial products company’s stock after buying an additional 2,738 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in SPX Flow were worth $483,000 as of its most recent SEC filing.

  • [By Max Byerly]

    SPX Flow (NYSE:FLOW) and NIPPON Stl & SU/S (OTCMKTS:NSSMY) are both industrial products companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on SPX Flow (FLOW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    FLOW stock traded up $0.73 on Wednesday, hitting $49.98. The company had a trading volume of 169,639 shares, compared to its average volume of 297,149. Flow International has a 12-month low of $31.10 and a 12-month high of $54.92.

    ILLEGAL ACTIVITY NOTICE: “$478.00 Million in Sales Expected for Flow International Corp (FLOW) This Quarter” was reported by Ticker Report and is owned by of Ticker Report. If you are reading this article on another website, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this article can be viewed at www.tickerreport.com/banking-finance/3362833/478-00-million-in-sales-expected-for-flow-international-corp-flow-this-quarter-2.html.

    About Flow International

  • [By Shane Hupp]

    Shares of Flowgroup PLC (LON:FLOW) were up 5% during mid-day trading on Wednesday . The company traded as high as GBX 0.01 ($0.00) and last traded at GBX 0.01 ($0.00). Approximately 27,087,413 shares changed hands during mid-day trading, a decline of 20% from the average daily volume of 34,010,000 shares. The stock had previously closed at GBX 0.01 ($0.00).

Hot Undervalued Stocks To Buy Right Now: ITT Corporation(ITT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P
  • [By Max Byerly]

    Wedge Capital Management L L P NC cut its holdings in shares of ITT Inc (NYSE:ITT) by 5.6% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 593,183 shares of the conglomerate’s stock after selling 35,351 shares during the quarter. Wedge Capital Management L L P NC’s holdings in ITT were worth $31,006,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in shares of ITT Inc (NYSE:ITT) in the second quarter, HoldingsChannel.com reports. The firm purchased 23,591 shares of the conglomerate’s stock, valued at approximately $1,233,000.

  • [By Motley Fool Transcribers]

    ITT Corp  (NYSE:ITT)Q4 2018 Earnings Conference CallFeb. 22, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Internet of Things Inc (CVE:ITT) shares traded down 16.7% during mid-day trading on Monday . The company traded as low as C$0.03 and last traded at C$0.03. 274,696 shares changed hands during mid-day trading, an increase of 101% from the average session volume of 136,706 shares. The stock had previously closed at C$0.03.

Hot Undervalued Stocks To Buy Right Now: A-Mark Precious Metals, Inc.(AMRK)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

Best Stocks To Invest In 2019

Customer service isn’t just about having a pleasant attitude or adopting a “the customer is always right” policy. Those things are important, but they’re only a few of the things a company needs to do to meet the needs of its patrons. Attitude and a willingness to serve become almost irrelevant if a store’s shelves don’t have the right merchandise, or a retailer does not offer the delivery or pickup model that meets a customer’s needs.

Currently, most retailers try to figure out the right mix to keep their customers happy using old-school techniques like observation and satisfaction surveys. Only 7% of retailers currently use artificial intelligence (AI) to enhance customer service. But that’s going to change: Another 48% plan to start using artificial intelligence technologies with 3 years according to the 2018 Customer Experience/Unified Commerce Survey.

AIs won’t always be in robot form, but they can be. Image source: Getty Images.

Best Stocks To Invest In 2019: First Trust Water ETF (FIW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Wells Fargo & Company MN decreased its stake in shares of First Trust Water ETF (NYSEARCA:FIW) by 11.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 275,540 shares of the company’s stock after selling 36,231 shares during the quarter. Wells Fargo & Company MN’s holdings in First Trust Water ETF were worth $13,256,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Raymond James & Associates increased its position in First Trust Water ETF (NYSEARCA:FIW) by 45.0% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 61,717 shares of the company’s stock after buying an additional 19,152 shares during the period. Raymond James & Associates’ holdings in First Trust Water ETF were worth $2,969,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    First Trust ISE Water Index Fund (NYSEARCA:FIW) declared a quarterly dividend on Thursday, June 21st, Wall Street Journal reports. Shareholders of record on Friday, June 22nd will be paid a dividend of 0.0861 per share on Friday, June 29th. This represents a $0.34 dividend on an annualized basis and a yield of 0.71%. The ex-dividend date of this dividend is Thursday, June 21st. This is a positive change from First Trust ISE Water Index Fund’s previous quarterly dividend of $0.06.

Best Stocks To Invest In 2019: Key Technology Inc.(KTEC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Press coverage about Key Technology (NASDAQ:KTEC) has been trending somewhat positive on Monday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Key Technology earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news coverage about the industrial products company an impact score of 47.5851902672258 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Best Stocks To Invest In 2019: Jack Henry & Associates Inc.(JKHY)

Advisors’ Opinion:

  • [By Max Byerly]

    Great Lakes Advisors LLC lowered its position in shares of Jack Henry & Associates (NASDAQ:JKHY) by 7.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,342 shares of the technology company’s stock after selling 524 shares during the quarter. Great Lakes Advisors LLC’s holdings in Jack Henry & Associates were worth $767,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Federated Investors Inc. PA lifted its stake in shares of Jack Henry & Associates, Inc. (NASDAQ:JKHY) by 227.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 100,518 shares of the technology company’s stock after purchasing an additional 69,837 shares during the quarter. Federated Investors Inc. PA’s holdings in Jack Henry & Associates were worth $13,104,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Jack Henry & Associates (JKHY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Stifel Financial Corp increased its position in Jack Henry & Associates, Inc. (NASDAQ:JKHY) by 12.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,616 shares of the technology company’s stock after acquiring an additional 6,990 shares during the period. Stifel Financial Corp’s holdings in Jack Henry & Associates were worth $7,436,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Royce & Associates LP lessened its holdings in shares of Jack Henry & Associates, Inc. (NASDAQ:JKHY) by 5.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 408,799 shares of the technology company’s stock after selling 21,500 shares during the quarter. Royce & Associates LP owned approximately 0.53% of Jack Henry & Associates worth $53,291,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Jane Street Group LLC raised its stake in Jack Henry & Associates, Inc. (NASDAQ:JKHY) by 104.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,367 shares of the technology company’s stock after acquiring an additional 3,765 shares during the period. Jane Street Group LLC’s holdings in Jack Henry & Associates were worth $891,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Best Stocks To Invest In 2019: Fossil Inc.(FOSL)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    President Trump will announce today if he will pull the United States out of the Obama-era nuclear deal. Trump wants European members of the treaty to amend certain issues regarding Iran’s uranium enrichment capacity. Energy stocks and oil prices had been rising on speculation that Trump would slap Iran again with economic sanctions, disrupting the region’s oil production. Comcast Corp. (Nasdaq: CMCSA) is currently working to obtain enough capital to purchase certain assets of Twenty-First Century Fox Inc. (NYSE: FOXA). The ability to raise capital would allow Comcast to replace Disney’s $52 billion bid for the many of Fox’s key businesses. Markets are reacting to a speech made this morning by U.S. Federal Reserve Chair Jerome Powell. During a speech in Zurich, Switzerland, Powell said that rising U.S. interest rates would not have a significant impact on emerging markets and foreign stock markets. This has long been a concern for other nations as the U.S. dollar rises and American bonds become more attractive to international investors.
    Four Stocks to Watch Today: DIS, C, SNAP
    The Walt Disney Co. (NYSE: DIS) will lead another busy day of earnings reports today. Investors will be exploring the impact of recent price hikes at the company’s theme parks, as well as the ongoing concerns about cable cutting and how this trend affects ESPN. Markets anticipate that the company will report earnings per share of $1.68 on top of $14.23 billion in revenue. Shares of Citigroup Inc. (NYSE: C) are on the move. The uptick came after activist investor ValueAct announced a $1.2 billion stake in the investment bank. Citigroup shares were up 1.2% in pre-market hours. Shares of Snap Inc. (NYSE: SNAP) gained 1% in pre-market hours. The owner of social media giant Snapchat said that its CFO Drew Vollero will step down next week. The executive will be replaced by a financial executive at Amazon.com Inc. (Nasdaq: AMZN). Snap continues to face incredible pressures after the f

  • [By Demitrios Kalogeropoulos]

    The S&P’s single best performer is a stock that many investors had left for dead before the start of the year. In fact, Fossil (NASDAQ:FOSL) shed 70% of its value in 2017 as demand for wearable tech disrupted its core watch business. The stock has rebounded lately thanks mainly to surprising strength in its new wearables segment. However, for shares to continue their growth, Fossil will need show that it can return to steady sales and profit gains. That isn’t likely this year, given that management is projecting revenue declines of between 14% and 6% in 2018, compared to an 8% drop last year.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Fossil Group, Inc. (NASDAQ: FOSL) which rose about 5% to $20.56. The stock’s 52-week range is $5.50 to $20.65. Volume was 1.5 million compared to the daily average volume of 2.1 million.

Best Stocks To Invest In 2019: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Chris Lange]

    Catalyst Biosciences Inc. (NASDAQ: CBIO) is scheduled to present interim data from its Phase 2 study of Marzeptacog alfa (MarzAA) on July 18. This data will be pertaining to the subcutaneous efficacy trial in individuals with hemophilia A or B with inhibitors to evaluate the ability of MarzAA to minimize spontaneous bleeding episodes.

  • [By Ethan Ryder]

    Catalyst Biosciences Inc (NASDAQ:CBIO) rose 2.7% on Wednesday . The stock traded as high as $10.75 and last traded at $10.54. Approximately 41,790 shares traded hands during trading, a decline of 93% from the average daily volume of 568,965 shares. The stock had previously closed at $10.83.

  • [By Joseph Griffin]

    B. Riley lowered shares of Catalyst Biosciences (NASDAQ:CBIO) from a buy rating to a neutral rating in a research report released on Thursday, MarketBeat reports. They currently have $12.50 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $44.00.

Best Stocks To Invest In 2019: ARMOUR Residential REIT, Inc.(ARR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ARMOUR Residential REIT (NYSE:ARR) was the target of some unusual options trading activity on Thursday. Stock traders acquired 657 call options on the stock. This represents an increase of approximately 1,163% compared to the typical volume of 52 call options.

  • [By Shane Hupp]

    Wells Fargo & Company MN decreased its position in shares of ARMOUR Residential REIT, Inc. (NYSE:ARR) by 19.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 201,989 shares of the real estate investment trust’s stock after selling 50,292 shares during the period. Wells Fargo & Company MN owned about 0.48% of ARMOUR Residential REIT worth $4,703,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    ARMOUR Residential REIT, Inc. (NYSE:ARR) declared a monthly dividend on Wednesday, May 30th, Wall Street Journal reports. Stockholders of record on Friday, June 15th will be paid a dividend of 0.19 per share by the real estate investment trust on Thursday, June 28th. This represents a $2.28 annualized dividend and a dividend yield of 9.72%. The ex-dividend date is Thursday, June 14th.

  • [By Max Byerly]

    Teacher Retirement System of Texas lowered its stake in ARMOUR Residential REIT, Inc. (NYSE:ARR) by 35.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,270 shares of the real estate investment trust’s stock after selling 4,991 shares during the period. Teacher Retirement System of Texas’ holdings in ARMOUR Residential REIT were worth $216,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    IndexIQ Advisors LLC trimmed its stake in ARMOUR Residential REIT, Inc. (NYSE:ARR) by 6.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,484 shares of the real estate investment trust’s stock after selling 2,444 shares during the period. IndexIQ Advisors LLC owned approximately 0.09% of ARMOUR Residential REIT worth $855,000 as of its most recent SEC filing.

Top 10 Value Stocks To Own Right Now

According to Goldman Sachs, hedge fund managers aren’t buying tech giant Apple Inc. (NYSE: AAPL).

Pundits are abuzz with theories. Maybe it’s because Apple has been forced to move iCloud data to Chinese data centers. Maybe these hedge fund managers know something the rest of us don’t. Or maybe they just think it’s overvalued.

Money Morning Chief Investment Strategist Keith Fitz-Gerald appeared on FOX Business Network’s “Varney & Co.” today to set the record straight. He was a Wall Street insider for decades before he started sharing his market-crushing secrets with our readers.

So when hedge fund investors say they’re not touching Apple, he knows what’s really going on…

Video  Keith Showed Readers 20 Triple-Digit Winners in 2017 (This Year Could Be Even Better)

Keith’s Money Map Report subscribers who followed along with his recommendations took down 20 triple-digit winners last year – including a 201.68% return and 132.35% gain that closed out in the same week.

Top 10 Value Stocks To Own Right Now: FMC Corporation(FMC)

Advisors’ Opinion:

  • [By ]

    FMC Corp (FMC) : “I like the way it’s bottoming and I think this level is good.”

    Pennsylvania Real Estate Investment (PEI) : “I think this REIT is cheap and they can pay that dividend, so you can own it.”

  • [By Beth McKenna]

    Most investors interested in gaining exposure to the lithium space should stick with investing in one or more of the large players listed on a major U.S. stock exchange:Albemarle Corporation(NYSE:ALB), FMC Corp. (NYSE:FMC), andSociedad Quimica y Minera de Chile(NYSE:SQM), or SQM. Smaller players are speculative to varying degrees, and most are unprofitable.

  • [By Benzinga News Desk]

    Weight Watchers (NYSE: WTW) is tipping the scales on Wall Street: Link

    ECONOMIC DATA
    USA Nonfarm Payrolls for Apr 164.0K vs 189.0K Est; Prior 103.0K. Private Payrolls for Apr 168.0K vs 194.0K Est; Prior 102.0K
    Unemployment Rate for Apr 3.90% vs 4.00% Est; Prior 4.10%
    New York Fed President William Dudley is set to speak at 12:45 p.m. ET.
    The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.
    Federal Reserve Bank of San Francisco President John Williams will speak at 3:00 p.m. ET.
    Randal Quarles, Vice Chairman for Supervision, is set to speak at 5:30 p.m. ET.
    Dallas Fed President Robert Kaplan will speak at 8:00 p.m. ET.
    Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 8:00 p.m. ET.
    Kansas City Fed President Esther George will speak at 8:00 p.m. ET.
    ANALYST RATINGS
    RBC upgraded Benefitfocus (NASDAQ: BNFT) from Sector Perform to Outperform
    Stephens upgraded FMC (NYSE: FMC) from Equal-Weight to Overweight
    RBC downgraded Colfax (NYSE: CFX) from Outperform to Sector Perform
    Deutsche Bank downgraded Smith & Nephew (NYSE: SNN) from Hold to Sell

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Jim Robertson]

    Last week, large cap FMC Corp (NYSE: FMC)reported Q1 2018 earnings with the CEO saying in the earnings call that they arelooking to separatetheir lithium assets in October in what will be thefirst U.S. IPO by a major lithium pure-play. In the earnings call, Chairman/CEO Pierre R. Brondeau stated:

Top 10 Value Stocks To Own Right Now: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for healthcare products and services usually isn’t discretionary. However, that doesn’t necessarily mean it makes sense to buy every healthcare stock out there. To find out what healthcare stocks it might make sense to buy this month, we asked top Motley Fool investors what companies are on their radar. In their view,Teva Pharmaceutical Industries (NYSE:TEVA), Novacure (NASDAQ:NVCR), and Galapagos (NASDAQ:GLPG)should be at the top of your idea list right now. Read on to find out why.

  • [By Lee Jackson]

    This stock has been on a roll and looks ready to break out. NovoCure Ltd. (NASDAQ: NVCR) develops and commercializes treatments for solid tumor cancer therapy called the tumor treating fields (TTFields). Its markets its proprietary TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer.

  • [By Chris Lange]

    NocoCure Ltd. (NASDAQ: NVCR) is scheduled to release its fourth-quarter earnings report on February 22 as well. The consensus estimates call for a net loss of $0.11 per share and $53.52 million in revenue. The same period of last year had a net loss of $0.26 per share and $30.24 million in revenue. Shares of Novocure most recently closed at $21.50, with a consensus price target of $27.00 and a 52-week range of $6.75 to $24.15.

  • [By Lisa Levin]

    Novocure Ltd (NASDAQ: NVCR) shares shot up 22 percent to $7.27 after the company posted a narrower-than-expected Q3 loss.

    Shares of TriNet Group Inc (NYSE: TNET) got a boost, shooting up 15 percent to $20.43. TriNet reported Q3 earnings of $0.29 per share on revenue of $770.5 million.

  • [By Brian Feroldi]

    After the company reported first-quarter results, shares of NovoCure (NASDAQ:NVCR), a medical device company focused on cancer, jumped as much as 10% in afternoon trading on Thursday. Shares closed the day up more than 9%.

Top 10 Value Stocks To Own Right Now: Atlas Energy, L.P.(ATLS)

Advisors’ Opinion:

  • [By Max Byerly]

    Atlas Energy Group (OTCMKTS: ATLS) and Transglobe Energy (NASDAQ:TGA) are both small-cap oils/energy companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Top 10 Value Stocks To Own Right Now: CPI Aerostructures, Inc.(CVU)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of CPI Aerostructures, Inc. (NYSE: CVU) got a boost, shooting up 25 percent to $7.10 after the company posted upbeat Q1 results.

    Wayfair Inc (NYSE: W) shares were also up, gaining 25 percent to $63.71 after first-quarter earnings boasted a 2.7-percent sales beat and 46-percent year-over-year increase in active customers.

  • [By Lisa Levin]

    Shares of CPI Aerostructures, Inc. (NYSE: CVU) were down around 14 percent to $7.30 on downbeat quarterly results.

    IDT Corporation (NYSE: IDT) was down, falling around 15 percent to $15.88 following Q2 results. IDT reported fiscal second-quarter earnings of $875,000.

Top 10 Value Stocks To Own Right Now: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

  • [By Lisa Levin]

    Shares of Catalyst Biosciences Inc (NASDAQ: CBIO) were down around 27 percent to $5.36. Catalyst Biosciences reported the pricing of $18 million offering of Class A units at $5 per unit

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

Top 10 Value Stocks To Own Right Now: Resonant Inc.(RESN)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares jumped 56.69 percent to close at $1.27 on Wednesday on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Vicor Corporation (NASDAQ: VICR) rose 26.84 percent to close at $37.10. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million.
    AGM Group Holdings Inc. (NASDAQ: AGMH) climbed 25.56 percent to close at $10.61.
    Travelzoo (NASDAQ: TZOO) gained 24.7 percent to close at $9.75 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) shares climbed 19.24 percent to close at $4.71.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 18.73 percent to close at $18.64.
    Genprex, Inc. (NASDAQ: GNPX) climbed 18.28 percent to close at $5.89. Genprex expanded its operations to Cambridge, Mass.
    Scorpio Tankers Inc. (NYSE: STNG) rose 13.92 percent to close at $2.70 following Q1 results.
    Rocky Brands, Inc. (NASDAQ: RCKY) shares surged 13.57 percent to close at $23.85 after reporting Q1 results.
    Resonant Inc. (NASDAQ: RESN) shares rose 12.5 percent to close at $4.14 on Wednesday.
    USANA Health Sciences, Inc. (NYSE: USNA) jumped 11.24 percent to close at $106.85 following Q1 results.
    SUPERVALU Inc. (NYSE: SVU) rose 11.16 percent to close at $16.24 after the company reported Q4 results and agreed to sell and leaseback eight distribution centers for an aggregate purchase price of $483 million.
    K12 Inc. (NYSE: LRN) shares gained 10.74 percent to close at $15.36 following Q3 results.
    Tupperware Brands Corporation (NYSE: TUP) rose 9.15 percent to close at $46.28 as the company posted in-line quarterly earnings.
    Six Flags Entertainment Corporation (NYSE: SIX) shares climbed 8.49 percent to close at $64.18 as the company posted a narrower-than-expected loss for its first quarter.
    Carlisle Companies Incorporated (NYSE: CSL) gained 8.2 percent to close at $107.94 af
  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose

Top 10 Value Stocks To Own Right Now: Apollo Gold Corporation(BRD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Bread (CURRENCY:BRD) traded 10.1% lower against the U.S. dollar during the 24-hour period ending at 15:00 PM ET on May 6th. Bread has a market cap of $73.13 million and approximately $1.09 million worth of Bread was traded on exchanges in the last 24 hours. One Bread token can currently be purchased for about $0.82 or 0.00008683 BTC on popular exchanges including OKEx, Binance and Cobinhood. In the last seven days, Bread has traded 3.3% higher against the U.S. dollar.

Top 10 Value Stocks To Own Right Now: Varex Imaging Corporation (VREX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Varex Imaging (VREX), a stock that wasn’t even in the index yesterday, soared to the top of the S&P 500 today after being spun out of Varian Medical Systems (VAR).

    Agence France-Presse/Getty Images

    Varex Imaging gained 7.3% to $27.27 today, while the S&P 500 declined 0.6% to2,280.90. Varian Medical Systems fell 1.2% to $77.68.

    Varian Medical Systems reported net income of $402 million on sales of $3.2 billion in 2016.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Fluor Corporation (NYSE: FLR) fell 13.4 percent to $51.10 in pre-market trading after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 9.8 percent to $28.97 in pre-market trading after surging 46.29 percent on Thursday.
    Gogo Inc. (NASDAQ: GOGO) shares fell 8.2 percent to $8.81 in pre-market trading after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 7.5 percent to $3.98 in pre-market trading after climbing 22.16 percent on Thursday.
    Arista Networks, Inc. (NYSE: ANET) fell 7.4 percent to $248.00 in pre-market trading following first-quarter earnings.
    Web.com Group, Inc. (NASDAQ: WEB) fell 6.7 percent to $18.00 in pre-market trading after reporting Q1 results.
    Varex Imaging Corporation (NASDAQ: VREX) fell 5.2 percent to $34 in pre-market trading after reporting Q2 results.
    Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) shares fell 5.2 percent to $7.60 in pre-market trading after dropping 3.02 percent on Thursday.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 4.7 percent to $61.70 in pre-market trading following Q1 earnings.
    HSBC Holdings plc (NYSE: HSEA) fell 4.6 percent to $25.15 in pre-market trading after reporting Q1 results.
    Stratasys Ltd. (NASDAQ: SSYS) shares fell 4 percent to $16.66 in pre-market trading after dropping 2.86 percent on Thursday.
    Melco Resorts & Entertainment Limited (NASDAQ: MLCO) fell 4 percent to $30.65 in pre-market trading.
    Century Aluminum Co (NASDAQ: CENX) fell 4 percent to $15.76 in pre-market trading following Q1 results.
    HSBC Holdings plc (NYSE: HSBC) shares fell 3.5 percent to $48.10 in pre-market tr

  • [By Jim Robertson]

    Small cap homeland security and screening stocks like FLIR Systems (NASDAQ: FLIR), OSI Systems (NASDAQ: OSIS),Varex Imaging Corp (NASDAQ: VREX) and Patriot One Technologies (OTCQB: PTOTF) stand to benefit fromTrumps focus on border andinternal security in general. Heres what you need to know about all four:

Top 10 Value Stocks To Own Right Now: Sun Hydraulics Corporation(SNHY)

Advisors’ Opinion:

  • [By Neha Chamaria]

    When Sun Hydraulics Corporation (NASDAQ:SNHY) reported its first-quarter 2018 numbers on May 7, the one thing that stood out in the earnings report was its top-line growth. Strong demand for industrial valves and electronics instrumentation combined with Sun Hydraulics’ opportunistic growth moves encouraged the company to upgrade its full-year sales outlook.

Top 10 Value Stocks To Own Right Now: Fox Factory Holding Corp.(FOXF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Fox Factory Holding Corp (NASDAQ: FOXF) was down 1.8 percent after posting a 2.16 percent rise over the day.

    Finally, Groupon Inc (NASDAQ: GRPN) gained 1.3 percent, continuing with the 3.85 percent spike it experienced on Friday trading.